OSP:rTTHc CCV / EuBiologics - LARVOL DELTA

Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children (clinicaltrials.gov) - P2 | N=390 | Recruiting | Sponsor: International Vaccine Institute

New P2 trial • Cholera

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults (clinicaltrials.gov) - P1 | N=150 | Completed | Sponsor: International Vaccine Institute | Recruiting ➔ Completed

Trial completion • Cholera

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults (clinicaltrials.gov) - P1 | N=150 | Recruiting | Sponsor: International Vaccine Institute | Not yet recruiting ➔ Recruiting | Trial completion date: Oct 2023 ➔ Jan 2024 | Trial primary completion date: Apr 2023 ➔ Jul 2023

Enrollment open • Trial completion date • Trial primary completion date • Cholera

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults (clinicaltrials.gov) - P1 | N=150 | Not yet recruiting | Sponsor: International Vaccine Institute

New P1 trial • Cholera